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Abstract
Background: Pancreatic cancer remains a fatal disease. Experimental systems are needed for personalized
treatment strategies, drug testing and to further understand tumor biology. Cell cultures can serve as an excellent
preclinical platform, but their generation remains challenging.
Methods: Tumor cells from surgically removed pancreatic ductal adenocarcinoma (PDAC) specimens were cultured
under novel protocols. Cellular growth and composition were analyzed and culture conditions were continuously
optimized. Characterization of cell cultures and primary tumors was performed via hematoxylin and eosin (HE) and
immunofluorescence (IF) staining.
Results: Protocols for two- and three-dimensional PDAC primary cell cultures could successfully be established.
Primary cell culture depended on dissociation techniques, growth factor supplementation and extracellular matrix
components containing Matrigel being crucial for the transformation to three-dimensional PDAC organoids. The
generated cultures showed to be highly resemblant to established PDAC primary cell cultures. HE and IF staining
for cell culture and corresponding primary tumor characterization could successfully be performed.
Conclusions: The work presented herein shows novel and effective methods to successfully establish primary
PDAC cell cultures in a distinct time frame. Factors contributing to cell growth and differentiation could be
identified with important implications for further primary cell culture protocols. The established protocols might
serve as novel tools in personalized tumor therapy.
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Background
Pancreatic cancer is one of the leading causes for cancer
related deaths worldwide [1]. Pancreatic ductal adenocar-
cinoma shows a dismal prognosis with a 5-year survival
rate of 9% [2]. Surgery remains the only curative treatment
option, but 80% of patients with PDAC are diagnosed in a
locally advanced or metastatic tumor stage and are not
eligible for surgery [3]. Despite intensive research efforts
and advances in systemic therapies, the median survival
for patients with metastatic PDAC remains less than a
year [4]. As patients with PDAC show a highly heteroge-
neous response to chemotherapeutic agents, there is a
necessity to develop personalized therapeutic strategies
[5–7]. Adequate preclinical models are needed, taking into
account, that resistance and response to cytotoxic therap-
ies are affected by a complex interaction between muta-
tional activity, intra- and intercellular signaling pathways
and cellular tumor composition [8–11]. Research has been
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focused on cell lines for various experiments, but they do
not reflect the in vivo situation [12–14]. It could be
shown, that established pancreatic cancer cell lines display
a completely different genetic structure than clinical sam-
ples of PDAC [15]. Primary cells from tumor tissue can
display the same properties as the originating tumor and
two- and three-dimensional primary cell culture models
from PDAC proved to be an excellent platform to study
tumor morphology and biology [16, 17]. However, efforts
to develop culture methods in an effective, time sparing
manner and recreating the in vivo conditions in an
in vitro setting have been challenging [11, 16–18]. A
multitude of factors are involved in primary cell culture
models: Tissue digestion techniques, culture media,
growth and differentiation factors as well as extracellular
matrix components [8, 19, 20]. In the study presented
herein, we established methods to create two- and three-
dimensional primary cell cultures from surgically resected
PDAC specimens. We focused on generating cell cultures
recapitulating distinct features of the originating tumor
and the evaluation of the aforementioned factors for suc-
cessful cell growth and differentiation.
Methods
Human samples
After the informed patient’s consent, specimens of 14
patients with histologically proven PDAC who under-
went a pancreaticoduodenectomy at the Department of
General, Visceral and Vascular Surgery, Charité - Uni-
versitätsmedizin Berlin, Germany, were collected and a
tissue specimen was mechanically extracted from the
center of the suspected tumor. The tissue specimen was
placed in a 50 ml tube containing 10ml CMRL medium
(Thermo Fisher) with penicillin/streptomycin (100 μg/
ml, Biochrom) and amphotericin b (2,5 μg/ml, Bio-
chrom), named Washing medium I (patient 01–11), or
Advanced RPMI 1640 Medium (Thermo Fisher) with
100 μg/ml penicillin/streptomycin, named Washing
medium II (patient 12–14) and was transferred on ice to
the laboratory of the Department of General, Visceral
and Vascular Surgery, Charité – Universitätsmedizin
Berlin. The average time from surgical removal of the
pancreatic tumor to the beginning of the tissue dissoci-
ation protocol in the surgical laboratory was 30 min. All
tumors of the originating specimen were examined for
their histopathological properties.
Coating
Cell culture plates were coated with collagen (10 μg/cm2,
Corning, incubated for 1 h, washed with Dulbecco’s
phosphate-buffered saline (DPBS, Thermo Scientific)
(patient 01–10), poly-l-lysine (100 μl/cm2, Sigma, incu-
bated for 30 min, washed with DPBS) (patient 02–10), or
left uncoated (patient 03–06; 08–14).
Culture media
Pancreas I medium (patient 01–08) consisted of CMRL
medium, penicillin/streptomycin (100 μg/ml), amphoter-
icin b (2,5 μg/ml), insulin-transferrin-selenium (5 μg/ml/
5 μg/ml/ 5 ng/ml, Sigma), nicotinamide (10 mM, Sigma),
bovine serum albumin (BSA, 2 mg/ml), hydrocortisone
(0,48 μg/ml, Stemcell) and human epidermal growth fac-
tor (hEGF, 20–50 ng/ml, Sigma). ROCK inhibitor Y-
27632 2 HCI (10–20 μM, Selleckchem) and retinoic acid
(200 nM, Sigma) were used for patient 03–08. For the
generation of Serum I medium (patient 09–11), fetal bo-
vine serum (FBS, 10%, Invitrogen) was added to Pan-
creas I medium. Organoid I medium (patient 12–13)
comprised Advanced RPMI 1640 Medium, 2% FBS,
HEPES buffer (10 mM, Thermo Fisher), l-glutamine (4
mM, Thermo Fisher), penicillin/streptomycin (100 μg/
ml), amphotericin b (2,5 μg/ml), insulin-transferrin-
selenium (5 μg/ml/ 5 μg/ml/ 5 ng/ml), nicotinamide (10
mM), B-27 (1%, Thermo Fisher), hydrocortisone (0,
48 μg/ml), fibroblast growth factor 2 (FGF2, 5 ng/ml,
Stemgent), and hEGF (50 ng/ml). The medium was
stored at 4 °C and used for one week. ROCK inhibitor Y-
27632 2 HCI (10 μM), platelet-derived growth factor
(PDGF, 1 ng/ml, Stemcell), insulin-like growth factor 1
(IGF, 1 ng/ml, Stemcell), fibroblast growth factor 10
(FGF10, 10 ng/ml, Sigma), retinoic acid (200 nM) and as-
corbic acid (20 μg/ml, Santa Cruz) were freshly added.
Organoid II medium (patient 14) consisted of Advanced
RPMI 1640 Medium, HEPES buffer (10 mM), l-
glutamine (4 mM), penicillin/streptomycin (100 μg/ml),
amphotericin b (2,5 μg/ml), insulin-transferrin-selenium
(5 μg/ml/ 5 μg/ml/ 5 ng/ml), nicotinamide (10 mM), B-
27 (1%) hydrocortisone (0,48 μg/ml), FGF2 (5 ng/ml),
and hEGF (50 ng/ml). The medium was stored at 4 °C
and used for one week. ROCK inhibitor Y-27632 2 HCI
(10 μM), PDGF (1 ng/ml), IGF (1 ng/ml), A 83–01
(1 μM), FGF10 (100 ng/ml), retinoic acid (200 nM), as-
corbic acid (20 μg/ml), r-spondin-1 (RSPO-1, 500 ng/ml,
Peprotech), wnt-3a (100 ng/ml, R&D Systems), [Leu15]-
gastrin I (10 nM, Sigma), noggin (100 ng/ml, Miltenyi)
and n-acetyl-l-cysteine 1 mM (Sigma) were freshly
added.
Establishment of two-dimensional cell cultures and PDAC
organoids
For an overview, see Table 2. Tissue culture was per-
formed under sterile conditions using a laminar flow
hood. Upon arrival at the laboratory, the removed PDAC
specimen was placed in a 35mm petri dish. A part of
the tissue was frozen in liquid nitrogen, another part
was fixed in 4% formalin for 24 h. All the following steps
were performed on ice, with cold medium and cooled
instruments. The largest part of the specimen used for
cell culture was weighed and covered with Washing
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medium I or II. Tissue fragments were mechanically
dissociated as small as possible with two sterile blades
(patient 01–08; 10–13) or a sterile blade and a for-
ceps (patient 14). Enzymatic digestion was performed
with with a mix of collagenase XI (1 mg/ml, Sigma),
DNAse I (4 μg/ml, Sigma) and trypsin (Thermo Scien-
tific), 1 ml per 0,1 g tissue, incubation time was 30
min at 37 °C and horizontal rotation with 300 rpm.
Digestion was stopped with Washing medium I, 2 ml
EDTA (50 mM, Thermo Scientific) and BSA (40 μl/ml,
Roth). Another centrifugation step was performed
with 450 g at room temperature, following resuspen-
sion in Pancreas I medium. The suspension was
rinsed through a 100 μm cell strainer (Corning) and
seeded onto cell culture dishes (patient 1–2). Samples
from patient 03–07 and 10 were digested with En-
zyme mix I (collagenase/dispase (1 mg/ml, Roche) and
4 μg/ml DNAse I), 1 ml (patient 03) or 2 ml (patient
04–07; 10) per 0,1 g tissue and incubated at 37 °C and
horizontal rotation with 300 rpm for one hour. After
30 min, trypsin/accutase (Thermo Scientific, 100 μl per
ml enzyme mix, patient 06), trypsin (100 μl/ml Enyme
Mix I, patient 06–07) or accutase (100 μl/ ml enzyme
mix, patient 10) were added. With Washing medium
I, the suspension was resuspended several times with
a 14 g cannula placed on a 20 ml syringe. The cell
suspension was then centrifuged with 200 g at 4 °C
for ten minutes, the supernatant was removed and
the cell pellet was resuspended in Pancreas I medium
(patient 03–07) or Serum I medium (patient 10) and
rinsed over a 40 μm cell strainer, transferred to a 15
ml falcon and centrifuged with 330 g at 4 °C for ten
minutes. The supernatant was again removed, the cell
pellet resuspended in Pancreas I medium (patient 03–
07) or Serum I medium (patient 10) and seeded onto
one well of a six well cell culture plate. Samples from
patient 11 were digested in two steps with collage-
nase/dispase and accutase, 30 min at 37 °C each with
two centrifugation steps at 440 g for 5 min at 4 °C.
After mechanical dissocation of samples from patient
12–14, for 250 mg of tissue, 1 ml of a freshly prepared
enzyme mix was added (enzyme mix was named En-
zyme Mix II). The enzyme mix consisted of DNAse I
(1,25 unit/ml, Sigma) hyaluronidase V (250 unit/ml,
Sigma), dispase (0,15 unit/ml, Corning) and elastase
(0,025 unit/ml, Sigma). Collagenase XI (0,5 mg, Sigma)
was added separately. Half of the enzyme mix was
placed on the PDAC tissue and mixed with a cut pip-
ette tip. The tissue was digested for 30 min at 37 °C.
After this first digestion, the tissue medium mix was
rinsed over the petri dish several times with a cut
pipette tip and then again chopped with a sterile
blade and treated with a syringe stamp. For the sec-
ond enzymatic digestion, the second half of the
enzyme mix and collagenase XI was added and incu-
bated for 45 min at 37 °C with horizontal rotation at
75 rpm. After incubation, the tissue medium mix was
again rinsed over the petri dish and then transferred
to a 100 μm cell strainer placed upon a 50 ml tube. 1
ml Washing medium II was rinsed over the cell
strainer four times to incorporate as much of the
digested tissue as possible. Cells in the flow through
were counted in a counting chamber and then centri-
fuged at 440 g for 5 min at 25 °C. Tissue fragment
culture comprised the preparation of 1–2 mm tumor
fragments with a sterile blade and placing of three to
six pieces onto one well of a six well cell culture dish
(patients 03–09). Primary cell culture medium was
added after the tissue fragments were adjacent to the
cell culture dish. Tumor fragments from samples
from patient 08 and 10 were placed together with en-
zymatically digested tissue in one cell culture dish.
For thin layer Matrigel based cell cultures (patient
05–11), the enzymatically digested and resuspended
cell pellet (patient 05–10: primary cell culture
medium; patient 11: primary cell culture medium with
5% Matrigel) or the preparated tumor fragments (pa-
tient 05–09) were seeded onto Matrigel coated cell
culture plates (50 μl/cm2, Corning, incubated for 30
min at 37 °C). For thick layer Matrigel based cell cul-
tures (patient 05–07; 09), the cell suspension was re-
suspended in Matrigel (150 μl/cm2), seeded onto non
coated cell culture plates and solidified at 37 °C for
30 min. On top assays with resuspension of cells in
Organoid I medium with 33% Matrigel (total volume
12 well: 750 μl; chamber slide (Corning): 300 μl) were
performed for patient 12 and 13. Organoid I medium
(12 well: 2 ml; chamber slide: 750 μl) was added and
cells were incubated at 37 °C. The protocol for patient
14 included placing 200 μl Matrigel in each well of a
12 well cell culture dish (24 well, 120 μl; chamber
slide: 120 μl) and incubation for 30 min at 37 °C to
solidify. When convex Matrigel formation was ob-
served, 50–100 μl of Matrigel were rinsed around the
edges of the cell culture plate as described previously
[21]. Cells were resuspended in 100 μl (24 well: 60 μl;
chamber slide: 60 μl) Organoid II medium. 100 μl Matrigel
were added (24 well: 60 μl; chamber slide: 60 μl) and
200 μl (120 μl) of the cell-Matrigel suspension were placed
on the Matrigel coated cell culture dishes and incubated
for 30min at 37 °C. For the first passage, a cell-Matrigel
ratio of 1:3 was used and seeded onto coated cell culture
plates. Within all described methods, medium was chan-
ged every three to four days and cell culture growth and
organoid formation was observed daily under the light
microscope (Eclipse TS 100, Nikon). Pictures were taken
with inverted light microscopes (Eclipse TS 100, Nikon;
Primovert with Axiocam 105 color camera, Zeiss).
Ehlen et al. BMC Cancer          (2020) 20:417 Page 3 of 13
Cell and organoid splitting
For passaging of cell cultures, trypsin (patient 05), tryp-
sin/accutase (patient 06) collagenase/dispase (patient 11)
and dispase (patient 12–13) were added until the whole
dish was covered, incubated at 37 °C and centrifuged.
The supernatant was removed, the cell pellet resus-
pended and seeded onto cell culture dishes. For mechan-
ical splitting (patient 14), medium was carefully removed
when organoids comprised more than 75% of the vol-
ume of the cell culture dish, 1 ml (12 well) of 4 °C cold
DPBS were added and the organoids within the Matrigel
were incorporated with a 1000 μl pipette tip and placed
in a 50ml tube with 15ml 4 °C cold DPBS. The cell cul-
ture dish was rinsed again with DPBS, the solution was
incorporated and added to the 50ml tube. The suspen-
sion was then centrifuged at 300 g at 4 °C for five mi-
nutes, the supernatant was removed until 4 ml were left
or the surface of the Matrigel-cell suspension at the bot-
tom of the tube was reached, another 10 ml 4 °C cold
DPBS were added, mixed and centrifuged again at 300 g
at 4 °C for five minutes. The supernatant was removed,
the cells were resuspended in primary cell culture
medium and Matrigel and placed on two wells of a
Matrigel coated cell culture dish as described before.
Paraffin sections, hematoxylin and eosin and
immunofluorescence staining
After fixation in 4% formalin for 24 h, primary tumor tis-
sue was processed for paraffin embedding with a stan-
dardized protocol. For HE and IF staining, 3–4 μm tissue
sections were prepared, mounted on a superfrost micro-
scope slide, placed in a drying cabinet (45–50 °C) for 24
h and then dried at 25 °C for one week. Deparaffinization
was performed with a standardized protocol. Tissue sec-
tions were stained with hematoxylin for 30 s to one mi-
nute and washed with tap water for six minutes. Eosin
staining was performed for five minutes. Sections were
incubated with distilled water, ethanol and Roti®-Histol,
mounted with Roti-Histokitt (Carl Roth) and dried
under a laminar flow hood for one day. For antigen
unmasking, microscope slides were placed into boiling
10mM sodium citrate buffer (pH 6.0) for 60 min, cooled
for 30 min, washed with DPBS once for one minute and
twice for five minutes. Paraffin sections were perme-
abilized with 0,5% Triton X-100 (Sigma) diluted in DBPS
for 10 min and then washed with DPBS for one minute
and twice for five minutes. Sections were blocked for 60
min with DPBS, 5% normal goat serum (Cell Signaling)
and 1% BSA at 25 °C (blocking solution). Paraffin sec-
tions were incubated with 50–100 μl of primary mouse
monoclonal antibodies against e-cadherin (Cell Signal-
ing, diluted 1:50), carbohydrate antigen 19–9 (CA 19–9,
Thermo Scientific, 1:100) or cytokeratin 19 (CK19,
Thermo Scientific, 1:100) and rabbit monoclonal
antibodies against cellular tumor antigen p53 (p53, Cell
Signaling, 1:50) and vimentin (Abcam, 1:200) in blocking
solution overnight at 4 °C. Sections were washed with
DPBS for one minute and three times for 15 min and
then incubated for 60 min at 37 °C with 50–100 μl goat
anti mouse Alexa Fluor 594 (Thermo Scientific, 1:250)
and goat anti rabbit Alexa Fluor 488 (Abcam, 1:500) sec-
ondary antibodies and 4′,6-diamidino-2-phenylindole
(DAPI, 1:10000) with 1% BSA. Sections were washed
with PBS for one minute and three times for 15 min and
cleansed with distilled water and embedded in antifade
mountant (ProTaqs® Mount Fluor). Glass plates were
placed into cell culture dishes and seeding of the
digested cell suspension or tissue fragment was per-
formed as described. Medium was removed and cells
were fixed with paraformaldehyde (Electron Microscopy
Sciences, 2–4%) or acetone-methanol for 5–30min at
25 °C, permeabilized with triton X-100 (Sigma, 0,5%)
and incubated with blocking solution containing 1%
BSA and 5–10% normal goat serum or a combination
with triton X-100 (0,1%) and tween20 (Promega, 0,1%)
diluted in DPBS for 60 to 90 min. Primary cells were in-
cubated with primary mouse monoclonal antibodies
against CA 19–9 (1:250), CK19 (1:250), e-cadherin (1:30)
and rabbit monoclonal antibodies against vimentin (1:
250) and p53 (1:50) overnight at 25 °C in blocking solu-
tion. Cells were washed with DPBS three times, incu-
bated for 30–120 min at 25 °C with 300 μl goat anti
mouse (1:250) and goat anti rabbit (1:500) secondary
antibodies and DAPI diluted 1:5000 in blocking solution
and washed with DPBS three times. In chamber slides,
medium was removed and primary cells containing
Matrigel was washed with DPBS. Cells were fixed with
750 μl paraformaldehyde (2–4%) and glutaraldehyde
(SERVA, 0,5%) diluted in DPBS for 30 min and then
washed three times for ten minutes with glycine
(TH.Geyer, 100 mM) diluted in DPBS. Permeabilization
was performed with 750 μl triton X-100 (0,5%) for ten
minutes. The organoid containing matrigel was washed
with 750 μl tween 20 (Promega, 0,1%), diluted in DPBS
three times for 10 min and incubated with 750 μl block-
ing solution containing 1% BSA and 10% normal goat
serum or a combination with fab fragment goat anti-
mouse (Jackson Immuno Research, 20 μg/ml), triton X-
100 (0,1%) and tween 20 (0,1%) diluted in DPBS for 90
min. Another washing step with 750 μl tween 20 (0,1%)
three times for 20 min with light horizontal rotation was
performed. All steps were performed at 25 °C and be-
tween each step, Matrigel and organoid structure were
controlled under the light microscope. Organoids were
incubated with 300 μl of primary mouse monoclonal
antibodies against CA 19–9 (1:50), CK19 (1:50), e-
cadherin (1:30) and rabbit monoclonal antibodies against
vimentin (1:100) and p53 (1:50) in blocking solution
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without fab fragments overnight at 25 °C. Chamber
slides were washed with 750 μl tween (0,1%) four times
for 20 min with light horizontal rotation and then incu-
bated for 90 min at 25 °C with 300 μl goat anti mouse (1:
250), goat anti rabbit (1:500) secondary antibodies and
DAPI diluted 1:5000 in DPBS with 1% BSA, 10% goat
serum, triton X-100 (0,1%) and tween 20 (0,1%) and
washed four times with 750 μl DPBS. Embedding in
mountfluor antifade mountant was performed. All im-
munofluorescence images were obtained with a laser
scanning microscope (LSM 510 META, Zeiss). For an
overview of antibodies and dilutions used see additional
Table 1.
Results
Patient demographic and histopathologic analysis
PDAC specimens of 14 patients who underwent a pan-
creaticoduodenectomy at the Department of General,
Visceral and Vascular Surgery, Charité - Universitätsme-
dizin Berlin, Germany, were immediately collected after
surgery with the informed patient’s consent. All patients
underwent a pylorus preserving procedure. Nine female
and five male patients with a mean age of 74 years were
included in the study and displayed a heterogenic exten-
sion of their disease, as it is summarized in Table 1. All
tumors were identified as pancreatic ductal adenocarcin-
omas by histopathological examination.
Establishment of two-dimensional cell cultures and PDAC
organoids
Primary cell cultures from tissue samples of 14 patients
with PDAC could be initiated and 11 primary cell
cultures could successfully be established (79%, named
PDACpxxcc). Organoid formation could be observed in
6 (43%) initiated cell cultures. Multiple methods were
performed and varied regarding coating of the cell cul-
ture plates, culture media, single cell and tissue fragment
seeding, digestion enzymes and Matrigel composition.
Cells could be propagated in culture for an average of
96 days (for an overview of performed culture techniques
see Table 2). An enzymatic digestion protocol was per-
formed with tissue samples from two patients without
Matrigel (PDACp01/02 cc). No cellular growth could be
observed (Table 2). Two cultures (PDACp03/04 cc)
could be established via outgrowth from tissue samples
adjacent to cell culture plates with a serum free cell cul-
ture medium based protocol (medium was named Pan-
creas I). Outgrowth from tissue samples could be
observed for 144 (PDACp03cc) and 123 (PDACp04cc)
days. Replacement of tissue samples onto novel cell cul-
ture dishes could be performed with similar outgrowth.
Polygonal epithelial monolayers with almost rectangular
shaped cells formed homogenous cobblestone-like pat-
terns and were surrounded by elongated convoluted
fibroblast-like cells. No difference in growth patterns be-
tween collagen or poly-l-lysine coated cell culture dishes
could be observed, whereas a higher percentage of tissue
fragments attached to collagen coated cell culture dishes
(Fig. 1). Matrigel containing cell cultures with Pancreas I
medium were performed. Primary cells were successfully
established and propagated for 194 days and seven pas-
sages (PDACp05cc). Thin layer Matrigel culture with an
overlay of a medium cell suspension was accomplished,
as well as cell suspension in Matrigel and direct seeding
on collagen coated cell culture dishes. After three days,
outgrowth from tissue fragments embedded in Matrigel
could be observed with polygonal cells in epithelial-like
clusters. Enzyme mix I, consisting of collagenase/dispase
and DNAse was used with an incubation time of one
hour at 37 °C, after centrifugation, cells were seeded and
formed clusters in Matrigel after seven days.
Cobblestone-like cellular patterns with scattered round
to oval cell islets with strong growth and small
organoid-shaped formations could be observed (Fig. 1).
Cell culture for PDACp06cc lasted 127 days with one
successful passage of tissue fragments (Fig. 1). Enzymatic
digestion with Enzyme mix I with and without trypsin/
accutase showed a low yield, especially without trypsin/
accutase. Another digestion step at day one was per-
formed with Enzyme mix I and trypsin and cultures
showed successful growth of elongated cells with rect-
angular shaped cell islets (Fig. 1). For PDACp07cc, no
cellular growth could be spotted. With Pancreas I
medium, primary cells from PDACp08cc lasted 113 days
in culture, tissue fragments could be passaged once, cells
could be passaged twice with a trypsin-based technique.
Table 1 Patient data
patient T N M G R L V
01 3 1 0 2 0 0 0
02 3 0 0 2 1 0 0
03 1 1 0 2 0 0 0
04 2 1 0 2 0 1 1
05 3 1 0 3 0 1 1
06 3 1 0 2 0 1 1
07 2 1 0 3 0 0 0
08 2 0 0 2 0 0 0
09 2 1 0 3 0 1 1
10 3 1 0 2 0 1 0
11 3 1 0 2 0 1 1
12 3 2 0 2 0 1 1
13 3 1 0 2 1 0 0
14 2 1 1 3 1 0 0
Pathological status of patients with histologically confirmed PDAC included in
the study. TNM classification system of the “International Union Against
Cancer” was utilized to describe extension of disease
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Elongated fibroblasts could be noticed, especially when
cells were attached to coated cell culture dishes. In
Matrigel, patterns of scattered, oval cells and in progres-
sing culture, polynuclear giant cells could be observed
(Fig. 1). Tissue fragment culture was prepared with the
PDACp09cc specimen with Serum I medium and lasted
81 days in culture. Outgrowth of convoluted and long fi-
broblasts from tissue fragments could be discovered, epi-
thelial cells were scattered in Matrigel. Different serum
containing media were tested. CMRL, DMEM and RPMI
containing cultures with high serum concentration
showed similar patterns of fibroblast growth with scat-
tered and progressively reducing epithelial cells. The
highest count of rectangular cells with epithelial morph-
ology was observed with Pancreas I medium and Matri-
gel (Fig. 1). A combined approach of placing tissue
fragments on a thin layer of Matrigel and an enzymati-
cally (Enzyme Mix I + accutase) digested cell suspension
was performed for PDACp10cc. Culture lasted 78 days,
in Matrigel, scattered incomplete organoid formation
and mixed cellular outgrowth with a high fibroblast
count was observed (Fig. 1). With a two step enzymatic
Table 2 Overview of culture protocols
Culture protocols performed for patients included in the study. Yellow marked x indicates successful performance
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digestion protocol, thin layer Matrigel and 5% Matrigel
containing cell culture medium, organoid growth for
PDACp11cc could be noted. Cells which migrated to the
bottom and attached to the cell culture dish formed
mixed epithelial and fibroblast clusters, lasted 56 days in
culture and could be passaged once (Fig. 1). A protocol
with two enzymatic digestion steps using Enzyme Mix
II, consisting of DNAse I, hyaluronidase V, dispase, elas-
tase and Collagenase XI and two mechanical dissociation
steps showed a high cellular yield. A concentration of
around 1 × 106 cells per cm2 cell culture dish could be
achieved. A technique with resuspension in 33% Matri-
gel was performed and medium with a lower serum con-
tent consisting of 2% FBS, hGEF, b27, ROCK inhibitor,
retinoic acid, FGF2, FGF10, PDGF and IGF as differenti-
ation factors was used (Organoid I medium). Organoid
outgrowth could be observed after six (PDACp12cc) and
eight (PDACp13cc) days. Cells which migrated to the
bottom of the cell culture dish showed a mixed epithelial
and fibroblast morphology with progressing fibroblast
growth. Organoids and cells lasted in culture for 51 days
and two passages (PDACp12cc) or 39 days and two pas-
sages (PDACp13cc), respectively (Fig. 1). With the tech-
nique of combined two step mechanical and enzymatic
digestion, a successful protocol for PDAC organoid cul-
ture could be established (Fig. 2). The implemented cell
culture medium (Organoid II) was serum free with
higher FGF10 concentrations (100 ng/ml). Noggin,
rspo1, wnt3a and gastrin were added as differentiation
and growth factors. Organoids lasted in cell culture up
to 48 days and could successfully be passaged (Fig. 1).
Matrigel concentrations were modified, for a well of a
six well cell culture dish, coating with 200 μl cold Matri-
gel (24 well: 120 μl; chamber slide: 120 μl) was per-
formed and incubated 30 min at 37 °C to reach optimal
viscosity. The optimal viscosity for on top implacement
of the cell-Matrigel suspension was reached when cells
were resuspended in Organoid II medium with 50%
Matrigel for at least 1 min (12 well: 200 μl; 24 well:
120 μl; chamber slide: 120 μl). With a cell-Matrigel ratio
of 1:3, similar organoid growth patterns could be seen.
After incubation for 30 min at 37 °C, Organoid II
medium with 5% Matrigel was added and successful
organoid growth could be observed (Fig. 2). Organoids
formed three-dimensional structures with distinct cen-
tral and peripheral cellular formations and resembled
established PDAC organoid cultures [9, 19].
Characterization of primary tumors and cell cultures
HE staining was performed for tumor specimens of 3 pa-
tients (PDACp12–14 t). Paraffin sections revealed dis-
tinct pathological patterns. PDACp12t showed an
Fig. 1 PDAC primary cell culture. Microscopic images of established primary cell cultures from patients 03–06 and 08–13 (representative images,
p indicates patient number, P number of passages and d days after culture initiation). Scale bars, 20 μm
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epithelial desmoplastic morphology and ductal forma-
tions with luminal muzine retention, PDACp13t dis-
played characteristic tubulous epithelial neoplasia and
PDACp14t exhibited cribriform and tubular ductal pro-
liferation patterns with a marked desmoplastic stromal
reaction as described in the clinical pathological report
(Fig. 3c). IF staining of CA 19–9, CK19, vimentin, e-
cadherin and p53 for primary cell cultures (PDACp03;
05;9-11 cc), a comparative analysis of primary tumors
from patients 12–14 and corresponding two- and three-
dimensional primary cell cultures was performed. Ex-
pression of epithelial or PDAC specific markers could be
detected in 87,5% of the stained primary cell cultures.
Outgrowing cells from tissue fragments on poly-lysine
coated glass plates from PDACp03cc showed vimentin
expression with isolated CA 19–9 expressing cells after
89 days in culture. IF from PDACp05cc after 183 days
revealed dissociated CA 19–9 and CK19 expression
without formation of ductal structures with surrounding
vimentin expressing fibroblasts. PDAC09cc displayed
vimentin and isolated CK19 expressing cells after 55 days
in culture. PDACp10cc showed vimentin expression, but
no expression of epithelial markers or p53 was observed.
PDACp11cc showed no p53 and CA 19–9 expression
after one passage and 55 days in culture and displayed
vimentin expressing fibroblasts, isolated CK19 express-
ing cells and islets with punctual e-cadherin expression
(Fig. 3b, Table 3a). Intermediate to high vimentin ex-
pression of fibroblasts could be observed in all primary
tumors, with scarce to intermediate vimentin expression
Fig. 2 Establishment of PDAC organoid cultures. a Microscopic images of PDAC organoids from patient 14 (PDACp14cc), 2–47 days after culture
initiation. Scale bars, 100 μm. b Different levels of three-dimensional organoids from PDACp14cc, 16–47 days after culture initiation. Scale
bars, 100 μm
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of all correlating cell cultures. All primary tumors
showed expression of the epithelial markers CK19 and
e-cadherin and the PDAC specific marker CA 19–9. CA
19–9 expression was observed in glandular proliferates
and could not be observed within poorly differentiated
cell clusters. IF staining of the corresponding primary
cell cultures revealed expression of CK19, e-cadherin or
CA 19–9 in all patients. PDACp12cc showed scarce e-
cadherin expression 14 and 34 days after culture initi-
ation. PDACp13cc organoids displayed marked mem-
branous expression of CK 19. E-cadherin expression
could be observed in PDACp14cc. Simultaneous expres-
sion of CK19, e-cadherin and CA 19–9 could not be ob-
served in primary cell cultures. IF staining of p53 was
performed with one positive staining of p53 for the pri-
mary tumor sample of patient 12 without p53 expression
of the corresponding cell culture (Fig. 3a, Table 3b).
Discussion
Recapitulating cellular architecture by gentle yet efficient
tissue dissociation techniques, recreating intercellular
signaling and cellular differentiation by balanced growth
factor supplementation and mimicking structures of
extracellular matrices are important factors for success-
ful cell culture [9]. PDAC shows a characteristic stromal
microenvironment with cancer-associated fibroblasts,
accessory cells and a dense meshwork of collagen, fibro-
nectin, proteoglycans, hyaluronic acid, blood and lymph-
atic vessels [22, 23]. One of the hallmarks of PDAC
primary cell culture is the dissociation of collagen type I
and III predominant dense stromal structures to enable
successful recapitulation of cellular structure in the
in vitro setting [24]. Previous studies showed different,
mostly mechanically and enzymatically combined ap-
proaches towards PDAC tissue dissociation with differ-
ent collagenase types, dispase, DNAse and trypsin [8, 9,
19, 25, 26]. In our study, the most effective protocol
comprised a two step approach by mincing with a com-
bination of a sterile blade and forceps and crushing with
a syringe stamp. The interaction between the two mech-
anical and two enzymatic digestion steps was crucial for
optimal tissue penetration of digesting enzymes on the
one hand and enzymatic tissue softening for optimal
mechanical effects on the other hand. The most effective
enzyme mix comprised collagenase XI, DNAse I and dis-
pase II with efficient proteolytic activity towards inter-
stromal cell connections, collagen type I and
hyaluronidase V to hydrolyze glycosidic linkages in hya-
luronic acid and elastase to address elastin fibers which
are associated with lysyl oxidase-like 2 mediated tumor
migration [27–31]. Cell culture media and added growth
and differentiation factors play a pivotal role in success-
ful cell culture initiation and should reflect in vivo con-
ditions as realistic as possible [32]. Huch et al. described
an organoid culture of pancreatic ducts from healthy
mice and showed EGF, nicotinamide, wnt agonist r-
spondin-1 and noggin, a protein involved in bone mor-
phogenic protein (BMP) – 4 inhibition, to be essential
for organoid formation and maintenance [33, 34]. Wnt
signaling promotes epithelial-mesenchymal transition
(EMT) in PDAC and the ligand wnt3a has been used in
PDAC cell culture before [35]. In a study describing the
Fig. 3 Immunofluorescence and hematoxylin and eosin staining. a Representative images of vimentin, CK19, CA 19–9, e-cadherin and p53
expression of primary cell cultures with organoid formation and corresponding tumors, indicated by IF staining. Scale bars, 20 μm. b IF staining of
vimentin, CK19 and CA 19–9 expression of two dimensional primary cell cultures (representative images). Scale bars, 20 μm. c HE staining of
primary tumors (representative image). Scale bars, 100 μm
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establishment of PDAC organoids from surgically
resected specimen with 80% efficacy, EGF, FGF10, nog-
gin, r-spondin-1, wnt3a, A83–01, a TGF-β inhibitor, pri-
mocin and gastrin (a downstream target of the wnt
pathway) were utilized [26]. Tsai et al. described a wnt
pathway ligand and TGF- β requirement for successful
organoid growth and used A83–01 and gastrin with a
success rate of 76% [26]. Interestingly, in one study, ret-
inoic acid, ROCK Inhibitor, insulin, hydrocortisone and
DBZ, a notch pathway inhibitor were used, whereas no
wnt3a and r-spondin are needed and noggin was
employed only for stem cell derived pancreatic progeni-
tor cultures [9]. Considering these heterogenous ap-
proaches and the complex alterations in signaling
pathways through neoplastic progression, it is
questionable how to translate insights from growth fac-
tor dependencies of stem cell and normal pancreatic tis-
sue cultures into primary tumor cell culture, as even no
correlation between organoid growth and specific addi-
tives is reported in literature [19]. In our study, BMP-4
and TGF-β inhibiting growth factors as well as r-
spondin-1 and wnt pathway ligands played a pivotal role
for organoid outgrowth but successful organoid out-
growth without dependency of the aforementioned
growth factors could be observed as well. Here, fibro-
blast growth factor FGF2 and 10, hEGF, IGF and PDGF
were used as PDAC shows an overexpression of their re-
ceptors, being associated with angiogenesis, desmoplastic
reaction and tumor growth [36]. Varying effects of retin-
oic acid and ROCK inhibition are described in primary
Table 3 Expression patterns of immunofluorescence staining
Expression profiles of vimentin, CK 19, CA 19–9, e-cadherin and p53 from cell cultures (PDACpxxcc) (a + b) and primary tumors (PDACpxxt) (b), detected by IF
staining. Expression patterns were defined as not present (−), scarce (+), intermediate (++) and high (+++). Blanc areas indicate non-performance due to limited
tissue availability
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cell culture, from promotion to inhibition of cellular
growth and differentiation [37, 38]. In our study, within
two-dimensional cell culture, adding retinoic acid and
ROCK inhibitor resulted in a boost of cellular growth. In
our opinion, more studies are needed to evaluate the
role of retinoic acid and ROCK inhibitor based culture
media for PDAC cell culture.
Serum contents in cell culture media promote cellu-
lar growth, but with PDGF releasing effects, they can
lead to fibroblast overgrowth [39]. In the work pre-
sented herein, culture with serum containing media
was successful, but higher fibroblast growth in two-
dimensional cell culture could be observed. With a
serum free approach, enzymatic digestion protocols
were not successful since cellular outgrowth could
only be observed in adjacent tissue fragments with
100% efficacy. Ruckert et al. described an efficacy of
9,25% for the isolation of pancreatic cancer cell lines
with a similar outgrowth method. Medium with a
high serum content and without other growth factors
was used, fibroblast overgrowth being the major prob-
lem during cell culture [16]. In the study presented
by Kim et al., an efficacy of 7,4% was reached with a
serum containing protocol and an intermittent fibro-
blast removal was performed to avoid overgrowth
[40]. In our opinion, serum concentrations should be
preferably low and specific factor containing ap-
proaches should be considered for successful out-
growth from tissue fragments. Besides the
aforementioned culture media requirements, intercel-
lular signaling especially from cell clusters, cellular
density and differentiation signaling from extracellular
matrix components seem to play a pivotal role in
promoting cellular growth and differentiation [8, 17].
In the work presented herein, only a high cellular
density with around 1 × 106 cells per cm2 cell culture
dish within enzymatic digestion protocols assured
successful organoid outgrowth. To our knowledge,
only one study evaluating initial cell seeding density
exists so far, focusing on in vitro formation of pan-
creatic endocrine cell cultures from embryonic stem
cells [41]. More studies are needed to evaluate stan-
dardized initial cell seeding counts for successful
PDAC primary cell culture.
Matrigel provides structure and growth factors from
the extracellular matrix and is an inevitable component
for successful organoid formation [9]. In our study, out-
growth of two-dimensional cell clusters from tissue frag-
ments was possible with low growth factor containing
cell culture media and without Matrigel. The attachment
of the fragments to cell culture dishes turned out to be
very important. This could indicate, that the high cellu-
lar density of tissue fragment culture is sufficient to pro-
mote primary cell growth without highly differentiated
cell culture media and without Matrigel. With enzymatic
digestion protocols and single cell suspensions with less
cellular density, only with Matrigel successful cellular
growth could be observed, using extracellular matrix
components not only for organoid culture but for mono-
layer cell cultures should be taken into account [42]. In
the work presented herein, only the combination of
Matrigel layers at the bottom of the cell culture dish
with an overlay of a 1:1 cell suspension - Matrigel mix-
ture, as well as an extension of the duration of Matrigel
solidification processes at 37 °C, showed to be highly ef-
fective. Differing Matrigel composition could be ob-
served. Based on our novel protocol, further studies
should evaluate Matrigel solidification time and struc-
ture to ensure successful embedding of primary cells
which was the hallmark of successful organoid
formation.
Previous studies showed different approaches defin-
ing the “right” organoid morphology and characteris-
tics, which resemble traits of the corresponding
tumor [8, 9, 19, 25, 26, 43]. Baker et al. described
organoid passaging for five or more times as sufficient
organoid propagation, which was achieved in 66% of
initiated cultures. No correlation between traits of the
originating tumor and corresponding organoids has
been made regarding cellular architecture or histo-
pathological features [43]. Boj et al. described murine
and human PDAC tumor models. Organoid morph-
ology was shown, as well as HE staining of organoids
and corresponding tumors. The analysis of resem-
blance was made through interpretation of cellular
morphology of tumor organoids compared to orga-
noids from non-malignant pancreatic tissue. Genetic
properties of organoids were analyzed through tar-
geted sequencing and showed heterogenous but
present mutations typical for PDAC [19]. In another
study, organoids of five patients were shown, present-
ing similar histological features and expression of the
differentiation markers KRT19, GATA6 and SOX9
[9]. Regarding two-dimensional culture, successful es-
tablishment of 5 cell lines from 54 patients with
PDAC, with successful initial outgrowth in 28 cases
in one study and the establishment of six cell lines
from 81 patients with PDAC were described. Com-
parative immunohistochemical analysis for CK8/18,
CDH, ezrin, p53, vimentin, SMAD4, KRAS, CK19,
p53 and DPC4 were performed, expression patterns
were divided into three levels with varying accordance
with the deriving tumor [16, 40].
Within the not yet standardized comparability assays
regarding the in vivo situation, in the work presented
herein, we provide a sufficient characterization of the
generated cell cultures, taking into account that this
study does not provide transcriptomic data as it could
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be described before [9, 19, 43]. The morphology of
the established cell cultures was microscopically ana-
lyzed and showed similar cellular patterns as de-
scribed PDAC primary cell cultures [9, 40]. For
further characterization, IF staining of primary cell
cultures and HE and IF staining of corresponding pri-
mary tumors could be performed with distinct expres-
sion patterns vimentin, CA 19–9, CK19 and e-
cadherin. Nevertheless, weaker expression profiles of
the stromal, epithelial and PDAC markers could be
observed as the high cellular density and intercellular
connections of primary tumors were not in total reca-
pitulated in the generated primary cell cultures. In
our opinion, further studies are needed to evaluate
the efficacy of tissue culture characterization tech-
niques regarding the predictability for successful ap-
plication of the generated cell cultures in personalized
medicine [8, 44].
Conclusions
Whereas the majority of the previous studies develop-
ing primary cell cultures from PDAC used stem cell
techniques or pancreatic explants from mice, to our
knowledge, only three methods for the culture of
two-dimensional primary cultures and only three
methods for the culture of organoids derived from
surgically resected PDAC specimens have previously
been described [9, 16, 20, 26, 40, 43]. In our study, a
comparatively high percentage of 79% initiated pri-
mary cell cultures from 14 patients with PDAC could
successfully be established. The established cell cul-
tures showed marked propagation capacities with an
average of 96 days. Two non Matrigel dependent and
9 Matrigel dependent cultures with two-dimensional
cellular cluster and 5 partial and one complete orga-
noid formations could be generated. Tissue digestion
methods, media supplements, cellular densitiy and
intercellular signaling influenced the generated pri-
mary cell cultures. A profound analysis for the mo-
lecular basis of methodical success was made.
Organoid formation showed to be highly dependent
on viscosity and concentration of Matrigel. Indicated
by organoid morphology, our results show that the
developed organoids resemble traits of established
organoid cultures [9, 19]. Primary cells were kept in
culture for 1 or 2 passages as the aim of this study
was not to create permanent cell lines, but passaging
up to 7 passages was possible, proving the durability
of the generated cell cultures. We present a valid
protocol for HE and IF staining to characterize originating
tumor specimen and primary cell cultures. Expression of
epithelial or PDAC specific markers could be observed in
87,5% of the stained primary cell cultures, conserving
tumor specific cellular composition.
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